skyrocketed Friday, up 120% on the news that French drug and vaccine giant Sanofi (SNY) is investing $1.2 billion in a deal for Novavax's COVID-19 vaccine as well as a minority stake in the struggling biotech company.
The deal gave Novavax a much-needed cash boost, helping it reverse more than a year of declining value.
"This is a new chapter in the history of our company,"…

#johnjacobs#yahoofinance#pfizer#pfe#jacobs#stanleyerck#sanofi#novavax